In summary, we have shown that the dynamic range of ER expression in the normal background epithelium surrounding breast carcinomas with low (1–10%) ER expression is lower than that of normal epithelium in other patient tissue samples, suggesting a weakness in the staining process rather than a reduction in biologic expression of ER in those tumors. The gene discussed is ESR1; the disease is breast carcinoma.